Use MDD (Medical Devices Directive)review to address illicit reuse, Eucomed pleads
This article was originally published in Clinica
Eucomed, the European medical device industry association, has expressed frustration that the European Commission has failed to address adequately the risks related to the reprocessing and reuse of single-use devices (SUDs) in its draft proposal for the revision of the Medical Devices Directive (MDD).
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.